跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Authorized
STANDARD
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Mylan Pharmaceuticals ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
30d323677e133c15
Company
Mylan Pharmaceuticals ULC
Type
Standard
Approval Details
Approval Id
30d323677e133c15
Drug Approval Canada Name
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Product Name
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Status
Marketed
Status Date
2021-03-12
Original Market Date
2021-03-12
Din
02498111
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AA09 BENDAMUSTINE
Atc Name
l 01 aa 09
Aig Number
0153268002
Company Name
Mylan Pharmaceuticals ULC
Company Address
85 Advance Road, Etobicoke, Ontario, Canada, M8Z 2S6
Active Ingredients
BENDAMUSTINE HYDROCHLORIDE
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
30d323677e133c15
Type
Standard
Back to Health Canada Approvals